Impact BioMedical Inc.
IBO
$0.78
$0.3268.47%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -53.47% | -28.23% | 215.89% | 66.89% | 361.72% |
| Depreciation & Amortization | 2.51% | 2.49% | 3.23% | 1.07% | -0.36% |
| Other Operating Expenses | -36.28% | 142.22% | 816.67% | 3,733.33% | 11.88% |
| Total Operating Expenses | 33.14% | -14.29% | 85.30% | 31.00% | -23.18% |
| Operating Income | -32.34% | 15.88% | -84.19% | -31.00% | 23.18% |
| Income Before Tax | 109.80% | -134.78% | -1,523.53% | -28.06% | -2,049.09% |
| Income Tax Expenses | -7,918.18% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 119.29% | -134.78% | -1,523.53% | -28.06% | -2,051.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -60.00% | -16.67% | 220.00% | -69.44% | -3.85% |
| Net Income | 119.35% | -134.61% | -1,513.72% | -31.70% | -2,094.98% |
| EBIT | -32.34% | 15.88% | -84.19% | -31.00% | 23.18% |
| EBITDA | 0.11% | 91.82% | -84.16% | -31.21% | 23.29% |
| EPS Basic | 102.48% | -132.67% | -1,224.30% | -9.15% | -5,521.24% |
| Normalized Basic EPS | 120.22% | -132.57% | -1,218.28% | -11.05% | -258.53% |
| EPS Diluted | 102.43% | -301.00% | -1,211.11% | -10.00% | -4,868.99% |
| Normalized Diluted EPS | 120.22% | -303.79% | -1,218.28% | -11.05% | -258.53% |
| Average Basic Shares Outstanding | 679.94% | 5.92% | 21.89% | 20.63% | -60.99% |
| Average Diluted Shares Outstanding | 679.94% | -83.08% | 21.89% | 20.63% | -60.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |